Clinical trial · Observational
Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer
Development of an Enhanced Risk Stratification System for Patients With Hospital-diagnosed Advanced Lung Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study explores whether supportive care interventions that might reduce rehospitalization could be implemented and feasible, in subjects within a high-risk group of subjects with newly diagnosed hospitalized advanced lung cancer (ALC). This study screened 50 subjects from health records and consented to 15 of these screened subjects. These 15 subjects responded to PRO questionnaires.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (3)
- label
- Low risk
- description
- Subjects will be considered low risk if they have non-small cell histology, a length of hospital stay \<= 8 days, no or low comorbidity, no emergency department use or hospitalization in the 6 months prior, no wheelchair requirement when hospital discharge, or other than Black and/or Hispanic race.
- label
- High risk
- description
- Subjects will be considered high risk if they have small cell histology, a length of hospital stay \> 8 days, high comorbidity, emergency department use or hospitalization in the 6 months prior, prescription of a wheelchair when hospital discharge, or Black and/or Hispanic race.
- label
- Health Care Providers Group
- description
- Thoracic medical oncology physicians, advance practice providers, and nurse navigators respond to the survey that assess acceptability.
Primary outcomes (4)
- measure
- Success of the risk-based stratification system implementation - contacted
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria for Patient Participants: 1. Age ≥ 18 years at the time of screening. 2. Hospital-diagnosed Advanced lung cancer with histological confirmation of disease or suspected lung cancer in the opinion of the treating oncologist. For PROs only 1\. Able to complete a web-based or telephonic symptom survey. Exclusion Criteria for Patient Participants: 1\. Enrollment in hospice upon discharge from the index hospitalization For PROs only 1. Inability to read or speak English. 2. Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent. 3. Current incarceration. 4. Any condition that would prohibit the patient from completing PROs Inclusion Criteria for Health Care Provider Participants: 1\. Thoracic medical oncology physicians, advance practice providers, and nurse navigators work in the study site and respond to the survey that assesses acceptability.
References
Publications (0)
Data not yet available